A complete cross-over design evaluating canine acceptance of Carprieve® and Rimadyl® carprofen chewable tablets in healthy dogs

  title={A complete cross-over design evaluating canine acceptance of Carprieve{\textregistered} and Rimadyl{\textregistered} carprofen chewable tablets in healthy dogs},
  author={Diana M A Dewsbury and Keith D Dedonder and Darrel James Rezac and Natalia Cernicchiaro},
  journal={BMC Veterinary Research},
BackgroundOsteoarthritis (OA) affects nearly 20% of all dogs greater than one year of age. Clinical signs include pain, discomfort, lameness, and ultimately lead to disability. Although there is currently no known cure, there are many therapeutic options that can slow the progression and alleviate the associated signs. There is ample supportive evidence demonstrating the efficaciousness of carprofen, a non-steroidal anti-inflammatory drug, in managing signs of OA. Since the approval of the… 

Tables from this paper


Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs.
Seventy dogs were included in a randomized, controlled, multicenter trial to test the efficacy of carprofen for relief of clinical signs associated with osteoarthritis, and two dogs had negative pretreatment and positive posttreatment fecal occult blood test results.
Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis
The reduction in lameness in the dogs treated with firocoxib was significantly greater than in the Dogs with osteoarthritis treated with carprofen, and this difference was statistically significant.
Clinical efficacy and pharmacokinetics of carprofen in the treatment of dogs with osteoarthritis
Six medium to large breed dogs with osteoarthritis were treated with 2 mg/kg of racemic carprofen, mixed with their morning feed, daily for 28 days, suggesting that carProfen was not accumulated and that tolerance to the drug did not develop.
Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis
Changes in the ground reaction forces were specific to the arthritic joint, and were significantly improved by carprofen and meloxicam but not by the nutraceutical; the values returned to normal only withmeloxicam.
Long-term treatment with carprofen of 805 dogs with osteoarthritis
The pain-relieving effect of carprofen and tolerance to the drug were investigated in 805 dogs that were lame as a result of osteoarthritis. The dogs were of different breeds, ages and bodyweights
Systematic review of the management of canine osteoarthritis
This review assesses the evidence for the efficacy of therapies used in the management of osteoarthritis in dogs on the basis of papers published in peerreviewed journals in English between 1985 and July 2007 to find a high level of comfort and a moderate level of Comfort for carprofen, firocoxib and meloxicam.
Palatability Testing of Oral Chewables in Veterinary Medicine for Dogs
This work compared acceptance and preference studies, as standardized methods are not established for informing formulation development or for more routine testing and dosage forms that are voluntarily accepted by animals are developed.
Comparative palatability of three commercial formulations of carprofen and one commercial formulation of firocoxib in dogs
Les comprimes de Rimadyl® ont presente une appetence significativement meilleure, en termes de choix, de prise et de consommation spontanes que celle des comprimes des trois autres produits Carprodyl®, Norocarp® et Previcox®.
Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs
Platelet aggregation decreased after treatment with aspirin and carprofen, whereas significant changes from baseline were not detected for the other drugs tested, suggesting decreased maximum amplitude and α-angle in dogs.
Pet Food Palatability Evaluation: A Review of Standard Assay Techniques and Interpretation of Results with a Primary Focus on Limitations
A review of palatability testing with dogs and cats addresses some of these limitations and indicates opportunities for future research.